PTTG1 and plasma cell myeloma: While expression of PTTG1 has previously been noted in gene expression signatures defining myeloma patients with highly proliferative disease [4] and chromosomal instability [35] and, by association, poor outcomes, this is the first study to show that PTTG1 expression alone is sufficient to identify a subset of patients with poor overall survival.